| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026659 |
| Receipt No. | R000030349 |
| Official scientific title of the study | Diagnosis of intestinal metaplasia in gastric mucosa uning Blue Laser Imaging(BLI) |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2017/03/23 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Diagnosis of intestinal metaplasia in gastric mucosa uning Blue Laser Imaging(BLI) | |
| Title of the study (Brief title) | Japan BLI intestinal metaplasia Study | |
| Region |
|
|
| Condition | ||
| Condition | Stomach tumor-related lesion | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Clarify the usefulness of BLI images to diagnose intestinal metaplasia in the background mucosa during the detailed examination of gastric tumor. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Gastric biopsied specimens will be taken from the green change mucosa suspicious of intestinal metaplasia by BLI images, compared with white light images. Similarly, specimens will be taken from brown change mucosa suspicious of non-intestinal metaplasia. Based on the pathological findings, sensitivity, specificity and accuracy will be evaluated. |
| Key secondary outcomes | Based on histological assessment of endoscopically resected specimens, the usufulness of BLI will be evaluated about the extent of tumor by color contrast between the tumor and the surrounding mucosa. In additon, the color difference will be measured using a color space International Lighting Commission recommended in 1976 in order to quantify such color contast and assess visibility of tumors by BLI. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Pathological diagnosis with endoscopy. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Over the 20 years old
2) Patient with gastric tumor acompanied by chronic gastric inflammatory mucosa. |
|||
| Key exclusion criteria | 1) Acute abdomen
2) Severe inflammation 3) Poor general condition patients who has risk for performing endoscopy such as ileus, perforation of intestine, pancreatitis respiratory disorder, heart failure, acquired hemophilia, stricture and large ulcer or tumor of digestive tract. 4) Patients who take peroral multiple drugs including anti-platelets and anti-coagulants, leading to difficulty to take a biopsy. 5) Patients who experienced entry of this study. 6) Patiens who is judged to be unsuitable for this clinical trial. 7) Patients who are difficult to be received the informed consent. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroyuki Osawa, M.D., Ph.D. |
| Organization | Jichi Medical University |
| Division name | Division of Gastroenterology |
| Address | 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498 JAPAN |
| TEL | 0285-58-7539 |
| osawa@jichi.ac.jp | |
| Public contact | |
| Name of contact person | Masahiro Okada, M.D. |
| Organization | Jichi Medical University |
| Division name | Division of Gastroenterology |
| Address | 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498 JAPAN |
| TEL | 0285-58-7539 |
| Homepage URL | |
| r0811mo@jichi.ac.jp | |
| Sponsor | |
| Institute | Jichi Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | FUJIFILM MEDICAL Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030349 |